{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-009743","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2024-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.272492+00:00","generated_at":"2026-06-04T22:26:10.639982+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"INBS raises $10.1M via private placement of common stock and warrants","bullets":["Gross proceeds of ~$10.1M from sale of shares, pre-funded warrants, Series H-1 and H-2 warrants at $4.55/unit.","Offering includes 2,223,333 shares, with warrants exercisable at $4.55; H-1 term 18 months post-SEC registration, H-2 five years reduced to 20 days after 510k clearance.","Proceeds to fund working capital, clinical trials for Intelligent Fingerprinting Drug Screening System, and market expansion.","Ladenburg Thalmann acted as exclusive placement agent; fees include 8% cash fee plus placement agent warrants at 125% of offering price.","Registration rights agreement: file resale registration statement by March 18, 2024, effective by April 22, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-009743","json":"https://secwatch.observer/filing/0001493152-24-009743.json","markdown":"https://secwatch.observer/filing/0001493152-24-009743.md","text":"https://secwatch.observer/filing/0001493152-24-009743.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224009743/0001493152-24-009743-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224009743/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:26:10.639982+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9990dff978eda84f0ca172e7c44d3340aab801ec","claim":"INTELLIGENT BIO SOLUTIONS INC. entered into Securities Purchase Agreement with several institutional and accredited investors (effective 2024-03-08).","evidence_excerpt":"On March 8, 2024, Intelligent Bio Solutions Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with several institutional and accredited investors","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224009743/0001493152-24-009743-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"several institutional and accredited investors"},{"label":"Effective","value":"2024-03-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}